(Q34630697)

3 August 2017

Use of recombinant interferon omega in feline retrovirosis: from theory to practice (English)

1 reference

3 August 2017

Ana Doménech

1

1 reference

3 August 2017

Guadalupe Miró

2

1 reference

3 August 2017

Victorio M Collado

3

1 reference

3 August 2017

Natalia Ballesteros

4

1 reference

3 August 2017

Leticia Sanjosé

5

1 reference

3 August 2017

Elena Escolar

6

1 reference

3 August 2017

Sonsoles Martin

7

1 reference

3 August 2017

Esperanza Gomez-Lucia

8

1 reference

3 August 2017

12 June 2011

1 reference

Veterinary Immunology and Immunopathology

3 August 2017

1 reference

3 August 2017

143

1 reference

3 August 2017

3-4

1 reference

3 August 2017

301-306

1 reference

Effect of type I interferons on the expression of feline leukaemia virus.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Retroviral infections of small animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Effects of type I interferons on Friend retrovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Anti-retroviral effects of type I IFN subtypes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Effect of type-I interferon on retroviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

A novel class of human type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Inhibition of feline leukemia virus replication by human leukocyte interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

The emerging role of innate immunity in protection against HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Immunomodulation therapy for feline leukemia virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Plasma electrophoretogram in feline immunodeficiency virus (FIV) and/or feline leukaemia virus (FeLV) infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Molecular cloning of feline interferon cDNA by direct expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Sensitivity of FCV to recombinant feline interferon (rFeIFN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: Consequences of recombinant feline interferon-ω administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Low-dose interferon-alpha treatment for feline immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Interferons, interferon-like cytokines, and their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Effects of interferon alpha (INF-alpha) therapy on peripheral blood lymphocyte subsets from FIV and FeLV naturally infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

The evolution of the type I interferons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Cat interferon inhibits feline leukaemia virus infection in cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

7 January 2021

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2',5'-oligoadenylate synthetase activity in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Cloning, expression, purification, and biological activity of five feline type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical alpha type of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2011.06.008

Oral use of human alpha interferon in cats

7 January 2021

1 reference

12 December 2020

Human interferon omega--a review.

1 reference

12 December 2020

Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats

1 reference

12 December 2020

Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro

1 reference

12 December 2020

Low-dose orally administered alpha interferon treatment for feline leukemia virus infection

1 reference

12 December 2020

10.1016/J.VETIMM.2011.06.008

Identifiers

DOI

1 reference

3 August 2017

1 reference